INTRODUCTION

Teneligliptin (TEN) (Fig. 1) is chemically [(2S,4S)-4-[4-(5-methyl-2-phenylpyrazol-3-
yl)piperazin-1-yl]pyrrolidin-2-yl]-(1,3-thiazolidin-3-yl)methanone. It is highly effective in lowering blood glucose levels. This drug inhibits the enzyme dipeptidyl peptidase-4 (DPP4) which degrades incretin, a hormone adjusting blood glucose control. It is effectively used to treat type-II diabetes mellitus [1] [2] . Metformin (MET) ( that plays an important role in insulin signaling, whole body energy balance and metabolism of glucose and fats [3] [4] [5] .
Literature survey reveals good number of analytical methods for the estimation of TEN and MET individually or in combination with other drugs using UV spectrophotometry [6] [7] [8] , HPLC [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] , HPTLC 20 and LC-MS/MS 21 . Moreover, few methods were reported for the estimation of the selected drugs in their combinations using UV spectrophotometry [22] [23] [24] , HPLC [25] [26] [27] [28] [29] . As 
EXPERIMENTAL
Materials & reagents
Reference standards of Teneligliptin and Metformin were provided as gift samples by Spectrum Labs, Hyderabad. Commercially available tablet formulation Tendia M tablets for the assay studies were purchased from local pharmacy. HPLC grade methanol, HPLC grade acetonitrile, analytical grade ortho phosphoric acid and HPLC grade water were purchased from Merck specialties, Mumbai, India.
Instrumentation
Development and validation of the method was performed on waters HPLC 2695 system equipped with quaternary pumps, auto sampler & photo diode array detector. Empower 2 software was applied for data collection and processing. 
Methodology
Preparation of standard stock solutions
The standard stock solutions of 200 µg/ml for TEN and 5000 µg/ml for MET were prepared by accurately weighing and transferring 2 mg of TEN and 50 mg of MET into 10 ml volumetric flasks. Added about three fourth of the volume with diluent, sonicated for 10 minutes. Finally, flasks were made up to the mark with diluent to obtain the mentioned concentrations. One ml of the above solution was pipetted out and transferred into a 10 ml volumetric flask and diluted up to the mark with diluent to obtain a concentration of 20 µg/ml for TEN and 500 µg/ml for MET.
Preparation of sample solution
Twenty tablets were weighed and average weight was calculated. Then they were powdered using mortar and pestle and the powder equivalent to 20 mg of TEN and 500 mg of MET was accurately weighed and transferred in to a 100 ml volumetric flask. 50 ml of diluent was added and sonicated for 25 min. Further the volume was made up with diluent to obtain a concentration of 200 µg/ml for TEN and 5000 µg/ml for MET. Filters of 0.45 micron size were employed for filtration purpose in the mentioned procedure. One ml of the above solution was pipette out and transferred into a 10 ml volumetric flask and diluted up to the mark with diluents to obtain a concentration of 20 µg/ml for TEN and 500 µg/ml for MET.
Preparation of buffer
One ml of ortho phosphoric acid was diluted to 100 ml with HPLC grade water to obtain 0.1% ortho phosphoric acid buffer.
Mobile phase
Buffer, acetonitrile and methanol were taken in the ratio of 65:25:10, v/v/v and was used as mobile phase. 
System suitability
System performance parameters like retention time, number of theoretical plates, tailing factor, resolution were calculated by injecting standard solutions for six times. The resultant results were compared with the standard limits as per guidelines.
Specificity
It is the ability of a method to discriminate between the analyte of interest and other components that are present in the sample. These studies are to check the interferences in the optimized method. To assess the method specificity, blank and placebo were injected into HPLC system under optimized conditions. There should not be any interfering peak in the blank or placebo chromatograms at the retention times of the selected drugs.
Linearity
The linearity of the method was obtained by preparation of the calibration standards of six different concentrations in 6 replicates. The calibration curve plots for TEN & MET were obtained by plotting the peaks areas on y-axis and concentrations on x-axis over the concentration ranges of 5-30 µg/ml for TEN and 125-750 µg/ml for MET. The correlation coefficient should be greater than 0.99.
Accuracy
The accuracy of the method was assessed by recovery experiments by adding a known quantity of pure standard drug into the sample solution and recovering the same in terms of its peak areas.
The sample was spiked with standard at levels of 50%, 100% and 150% of test concentrations.
u n c o r r e c t e d p r o o f
The resultant spiked sample was assayed in triplicate. The %recovery for each level should be in between 98%-102%.
Precision
It is the degree of closeness of agreement between the series of measurements obtained from multiple sampling of the same homogenous sample under prescribed conditions. It is expressed in terms of standard deviation (SD) or relative standard deviation (RSD). Precision may be measure of either degree of repeatability or reproducibility of the analytical method.
Method precision: Sample solutions were injected under optimized conditions for six times on six different days and their peak areas were recorded. %RSD for the peak areas of 6 standard injection results should not be greater than 2.
Intermediate precision: Six replicates of sample solutions were injected under optimized conditions on the same day and their peak areas were recorded. %RSD for the peak areas of 6 replicate injection results should not be greater than 2.
Ruggedness
The ruggedness of the method was determined by carrying out the experiment on different instruments, by different operators and using different columns of similar types.
Robustness
The robustness of the method was determined by making small deliberate changes in the method like flow rate, mobile phase ratio & temperature. But, one should not find remarkable change in the results and the obtained results should be within range as per ICH guidelines.
Effect of variation of flow:
Sample was analyzed at 0.9 ml/min & 1.1 ml/min flow rate instead of 1.0 ml/min, remaining conditions are kept constant. min. For oxidative degradation 20% v/v, H2O2 was used and the same was refluxed at 60°C for 30 min. For thermal degradation, sample was placed in oven at 105°C for 6 hr; and for photo stability degradation, drug was exposed to UV light by keeping the sample in UV chamber for 7 days or 200 watt hours/m 2 in photo stability chamber; for neutral degradation, the drugs were refluxed in water for 6 hours at a temperature of 60°C. All the samples were diluted to obtain a final concentration of 20 µg/ml of TEN & 500 µg/ml of MET. Ten micro liters of the samples were injected into the system and the chromatograms were recorded to assess the stability of the sample.
Solution Stability
The stability of the drug solution was determined for the short term stability, auto sampler stability. Short term stability was carried out by keeping the samples, at room temp (25°C) for 24 hrs. Auto sampler stability was determined by storing the samples for 24 hrs in the auto sampler.
Each sample was injected 6 times into HPLC & the results obtained were compared with nominal values of QC samples.
RESULTS
The results of optimized chromatographic conditions were shown in Table 1 . System suitability parameters (tailing factor, retention time & theoretical plates) were found to be within acceptance criteria. Summary of system suitability parameters were tabulated in Table 2 . We did not find any interfering peaks at the retention times of TEN & MET (Fig. 3) , which declares that the method is specific. The quantification was linear in the concentration range of 5-30 µg/ml for TEN with a correlation coefficient 0.999 (Fig. 4) ; 125-750 µg/ml for MET with a correlation coefficient 0.999 (Fig. 5) respectively. The results of linearity were tabulated in Table 3 . The recoveries of TEN and MET were found to be in the range of 99.35-99.94% and 99.80-100.61%
respectively. The results were compared with the guidelines & expressed as percentages and the results were given in Table 4 . The precision of the method is satisfactory as %RSD is NMT 2%. Table 5 . No remarkable changes in the results were notice in robustness studies and hence the method is robust. The results were tabulated in Table 6 . The assay results were compared with the labeled claim of TEN & MET marketed formulation and the results were tabulated in Table   7 . The LOD & LOQ values were calculated using slope and standard deviation values and the same were tabulated in Table 8 .
Forced degradation study u n c o r r e c t e d p r o o f
The standard solutions were subjected to different stress conditions as mentioned in the procedure. Under acidic conditions, drugs showed degradation of about 3.66% for TEN & 3.14% for MET and we have noticed about 3 degradation peaks (Fig. 6) . Under alkali conditions, drugs showed degradation of about 2.75% for TEN & 2.67% for MET and 2 degradation peaks were noticed (Fig. 7) . Under oxidative conditions, drugs showed degradation of about 1.01% for TEN & 1.62% for MET and 1 degradation peak was noticed (Fig. 8) . Under remaining conditions, thermal, photo stability and neutral conditions, the degradation was less than 1% for both the drugs and no degradant peak was noticed ( Fig. 9-11 ). Result of forced degradation studies are tabulated in Table 9 .
Stability studies
The drug solutions were found to be stable for 24 hrs at 25°C for short term stability and 24 hrs for auto sampler stability. 
